11/07/2024
5:33 AM | Moderna (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/08/2024
3:19 PM | Mock James M (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
7:49 AM | Hussain Abbas (Reporting)
Moderna (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/04/2024
7:52 AM | Hussain Abbas (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
6:03 AM | Moderna (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/12/2024
5:03 AM | Moderna (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/10/2024
3:15 PM | Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
09/09/2024
2:29 PM | Klinger Shannon Thyme (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/04/2024
4:42 PM | Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
3:26 PM | Hoge Stephen (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
2:42 PM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/30/2024
3:34 PM | Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2024
3:37 PM | Mock James M (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
3:45 PM | Mock James M (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/28/2024
3:30 PM | Klinger Shannon Thyme (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/13/2024
3:33 PM | Hoge Stephen (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
3:02 PM | Moderna (Issuer)
Rubenstein David M. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/02/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
5:31 AM | Moderna (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/26/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2024
3:19 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/23/2024
6:05 AM | Moderna (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
3:23 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/15/2024
10:44 AM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/12/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2024
3:19 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/09/2024
3:34 PM | Mock James M (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2024
2:28 PM | Mock James M (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/28/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2024
3:19 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/21/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
3:28 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
11:45 AM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2024
3:20 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/11/2024
6:01 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
4:41 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/11/2024
4:26 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2024
2:16 PM | Klinger Shannon Thyme (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
There is a little known company that is changing warfare (Ad) With geo - political instability around the world investors are flocking to defense contract stocks.
There is a little known company that is changing warfare. With the backing of U.S. government contracts, this startup is reshaping the future of the U.S. military. Click here to gain instant access to one of the most exclusive pre-ipo opportunities in the market t |
06/05/2024
3:22 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/04/2024
4:27 PM | Mock James M (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
4:20 PM | Hoge Stephen (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
2:36 PM | Klinger Shannon Thyme (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024
2:20 PM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024
2:11 PM | Mock James M (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/31/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
3:36 PM | Mock James M (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
3:34 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2024
3:12 PM | Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
2:12 PM | Mock James M (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2024
2:14 PM | Garay Arpa (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2024
2:20 PM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2024
2:22 PM | Klinger Shannon Thyme (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/28/2024
2:21 PM | Mock James M (Reporting)
Mock James M (Reporting)
Moderna (Subject)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/28/2024
2:21 PM | Klinger Shannon Thyme (Reporting)
Moderna (Subject)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/24/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
3:27 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/17/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
3:23 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/15/2024
12:41 PM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/13/2024
3:03 PM | Hoge Stephen (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
3:43 PM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/08/2024
3:24 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/07/2024
3:51 PM | LANGER ROBERT (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
3:54 PM | Horning Sandra (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
3:57 PM | Moderna (Issuer)
Tallett Elizabeth E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
3:59 PM | Moderna (Issuer)
SAGAN PAUL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
4:02 PM | Moderna (Issuer)
Nader Francois (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
3:42 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
5:31 AM | Moderna (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/24/2024
3:21 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/19/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
3:17 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/16/2024
3:23 PM | Hoge Stephen (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2024
9:58 AM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/12/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
3:22 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2024
1:03 PM | Moderna (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
04/09/2024
3:09 PM | Mock James M (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
2:32 PM | Mock James M (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/05/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
3:20 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/29/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
3:22 PM | AFEYAN NOUBAR (Reporting)
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/22/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
7:46 AM | Moderna (Filer)
| Form DEF 14A | |
Has Trump Finally Gone Too Far? (Ad) Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks.
It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives.
But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars.
And here's the good news. Register For The Webinar To Discover |
03/21/2024
7:47 AM | Moderna (Filer)
| Form DEFA14A | |
03/19/2024
3:39 PM | Hoge Stephen (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
11:12 AM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024
8:30 AM | Moderna (Filer)
| Form ARS | |
03/13/2024
3:24 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
8:05 AM | Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
2:22 PM | Klinger Shannon Thyme (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2024
2:13 PM | Garay Arpa (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
